Video: “How clinical trials have changed prostate cancer care”

March 2018 Awareness Night How clinical trials have changed prostate cancer care   Dr. Andrew Loblaw BSc MD MSc FRCPC CIP Clinician Scientist , Ontario Association of Radiation OncologyStaff Radiation Oncologist & Clinician Scientist, Sunnybrook Health Sciences Centre Scientist, Sunnybrook Research Institute Fellow, American Society of Clinical Oncology  (ASCO) Co-Chair, GU group for Cancer Care Ontario’s Program in Evidence-Based Care Previous Co-Chair, ASCO’s Genitourinary Advisory Group Professor, Department of Radiation Oncology at University of Toronto Professor,The Institute of Health Policy, Management and Evaluation (IHPME) CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 66:27 minutes 

Video: “Brachytherapy for Prostate Cancer and Breast Cancer”

September 2017 Awareness Night Brachytherapy for Prostate Cancer and Breast Cancer Dr. Juanita Crook, MD, FRCPC Professor of Radiation Oncology, University of British Columbia Radiation Oncologist,  Center for the Southern Interior in Kelowna BC             CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 47:27 minutes

High-dose radiation therapy as effective as surgery for aggressive prostate cancer

A study by researchers at the UCLA Jonsson Comprehensive Cancer Center provides convincing evidence that radiation-based treatments and surgery are equally effective treatments for aggressive prostate cancer. It also suggests that a particular form of radiation therapy, consisting of external radiation followed by brachytherapy (a type of radiation treatment in which a radioactive source is placed into the tumor directly) provides the best chance of preventing metastatic disease. Read the article here.

Cesium-131 Brachytherapy

Some experts see Cesium-131 as an optimal version of brachytherapy because it is both fast-acting and has a shorter delivery time than other brachytherapies — about 30 days. A key advantage is shorter recuperation periods, meaning patients can recover their urinary, bowel, and sexual functions quicker than with other brachytherapy solutions. Read the article here.

Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers

Brachytherapy, a form of localized radiation therapy, has been shown to be one of the most effective methods for delivering high radiation doses to the cancer; however, recent evidence suggests that increasing the localized radiation dose without bound may cause unacceptable increases in long-term side effects. This review focuses on methods that have been proposed, or are already in clinical use, to safely escalate the dose of radiation within the prostate. Read the article here.

Scroll to Top